Trial intelligence / Profile preview

Preparing Smokers with Mental Illness to Quit

NCT01783912Phase 4Completed

Sponsor
University of Wisconsin–Madison
Start
Dec 2012
Primary completion
Jun 2014
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of nicotine patch in nicotine dependence (3 arms), sponsored by University of Wisconsin–Madison. Primary endpoint: Acceptance of Wisconsin Tobacco Quit Line Services. Started Dec 2012; status: completed.

02

Drugs

nicotine patch
03

Conditions

nicotine dependence

Beyond the preview

Go deeper on NCT01783912.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01783912.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call